These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11768586)

  • 1. A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease).
    Voznyi YV; Keulemans JL; van Diggelen OP
    J Inherit Metab Dis; 2001 Nov; 24(6):675-80. PubMed ID: 11768586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type II (Hunter syndrome)].
    Zhang WM; Shi HP; Li BT; Zhao SM; Qi QW; Sun NH; Huang SZ
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):644-7. PubMed ID: 17217652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease type D (MPS IIID).
    He W; Voznyi YaV ; Boer AM; Kleijer WJ; van Diggelen OP
    J Inherit Metab Dis; 1993; 16(6):935-41. PubMed ID: 8127069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of mucopolysaccharidosis type II by measurement of iduronate-2-sulfatase in dried blood spots and plasma samples.
    Dean CJ; Bockmann MR; Hopwood JJ; Brooks DA; Meikle PJ
    Clin Chem; 2006 Apr; 52(4):643-9. PubMed ID: 16497940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease C (MPS III C).
    Voznyi YaV ; Karpova EA; Dudukina TV; Tsvetkova IV; Boer AM; Janse HC; van Diggelen OP
    J Inherit Metab Dis; 1993; 16(2):465-72. PubMed ID: 8412007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A).
    van Diggelen OP; Zhao H; Kleijer WJ; Janse HC; Poorthuis BJ; van Pelt J; Kamerling JP; Galjaard H
    Clin Chim Acta; 1990 Feb; 187(2):131-9. PubMed ID: 2107987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iduronate sulfatase activity in serum, lymphocytes, and fibroblasts--simplified diagnosis of the Hunter syndrome.
    Liebaers I; Neufeld E
    Pediatr Res; 1976 Aug; 10(8):733-6. PubMed ID: 821034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis of the Hunter syndrome and the introduction of a new fluorimetric enzyme assay.
    Keulemans JL; Sinigerska I; Garritsen VH; Huijmans JG; Voznyi YV; van Diggelen OP; Kleijer WJ
    Prenat Diagn; 2002 Nov; 22(11):1016-21. PubMed ID: 12424767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct assay of iduronate-2-sulfatase for Hunter disease using UPLC-tandem mass spectrometry and fluorogenic substrate.
    Lee K; Jun SH; Song SH; Park HD; Park KU; Song J
    Clin Biochem; 2015 Dec; 48(18):1350-3. PubMed ID: 26297117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The iduronate sulphatase activities of cells and tissue fluids from patients with Hunter syndrome and normal controls.
    Dean MF
    J Inherit Metab Dis; 1983; 6(3):108-11. PubMed ID: 6422140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel fluorometric enzyme analysis method for Hunter syndrome using dried blood spots.
    Tolun AA; Graham C; Shi Q; Sista RS; Wang T; Eckhardt AE; Pamula VK; Millington DS; Bali DS
    Mol Genet Metab; 2012 Mar; 105(3):519-21. PubMed ID: 22227323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chaperone effect of sulfated disaccharide from heparin on mutant iduronate-2-sulfatase in mucopolysaccharidosis type II.
    Hoshina H; Shimada Y; Higuchi T; Kobayashi H; Ida H; Ohashi T
    Mol Genet Metab; 2018 Feb; 123(2):118-122. PubMed ID: 29289480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorometric measurement of alpha-L-iduronidase activity using 4-methylumbelliferyl-alpha-L-iduronide.
    Minami R; Watanabe Y; Kudoh T; Oyanagi K; Nakao T
    Tohoku J Exp Med; 1980 Apr; 130(4):381-4. PubMed ID: 6781103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the two iduronate-2-sulfatase cDNAs.
    Daniele A; Di Natale P
    Biochem Mol Biol Int; 1995 Jun; 36(2):311-7. PubMed ID: 7663435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.
    Lin SP; Chang JH; Lee-Chen GJ; Lin DS; Lin HY; Chuang CK
    Clin Chim Acta; 2006 Jul; 369(1):29-34. PubMed ID: 16480701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for measuring disease-specific iduronic acid from the non-reducing end of glycosaminoglycan in mucopolysaccharidosis type II mice.
    Shimada Y; Wakabayashi T; Akiyama K; Hoshina H; Higuchi T; Kobayashi H; Eto Y; Ida H; Ohashi T
    Mol Genet Metab; 2016 Feb; 117(2):140-3. PubMed ID: 26051019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the organisation of coding sequences within the iduronate sulphate sulphatase (IDS) gene.
    Flomen RH; Green EP; Green PM; Bentley DR; Giannelli F
    Hum Mol Genet; 1993 Jan; 2(1):5-10. PubMed ID: 8490623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl.
    Semyachkina AN; Voskoboeva EY; Zakharova EY; Nikolaeva EA; Kanivets IV; Kolotii AD; Baydakova GV; Kharabadze MN; Kuramagomedova RG; Melnikova NV
    BMC Med Genet; 2019 May; 20(1):66. PubMed ID: 31046699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iduronate sulfatase determination for the diagnosis of the Hunter syndrome and the detection of the carrier state.
    Neufeld EF; Liebaers I; Lim TW
    Adv Exp Med Biol; 1976; 68():253-60. PubMed ID: 820168
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluorometric measurement of urinary alpha-L-iduronidase activity.
    Isemura M; Kosaka H; Ikenaka T; Kido R; Yoshimura T
    J Biochem; 1978 Sep; 84(3):627-32. PubMed ID: 102641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.